Skip to main content

iwCLL 2025 Main banner

iwCLL X / Twitter

103 Views

Poster

1412 - Real-world Utilization of Novel Therapies and Overall Survival among U.S. Medicare Beneficiaries Initiating Frontline Chronic Lymphocytic Leukemia Treatment

Primary Author(s)

SH

Scott F. Huntington, MD, MPH, MSc

Yale Cancer Center
New Haven, Connecticut, United States

Co-Author(s)

JP

Justin T. Puckett, BA

COVIA Health Solutions
Lansdale, Pennsylvania, United States

Co-Author / Presenter(s)

BM

Beenish S. Manzoor, PhD, MPH

AbbVie Inc.
North Chicago, Illinois, United States

Co-Author(s)

SL

Sophia Li, MPH

Genentech Inc.
South San Francisco, California, United States
YM

Yves Paul Mbous, PhD

AbbVie, Inc.
North Chicago, Illinois, United States
CR

Carolina Reyes, PhD

Genentech Inc.
South San Francisco, California, United States
NE

Nnadozie Emechebe, PhD, BPharm

AbbVie Inc.
North Chicago, Illinois, United States
SK

Sachin Kamal-Bahl, PhD

COVIA Health Solutions
Lansdale, Pennsylvania, United States
HB

Holly Budlong, PharmD, PhD, BCPS

AbbVie, Inc.
North Chicago, Illinois, United States
JD

Jalpa A. Doshi, PhD

University of Pennsylvania
Philadelphia, Pennsylvania, United States